Loading…

Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats

We aimed to evaluate the combining effects of transarterial chemoembolization (TACE) and open local thermal microwave ablation in a hepatocellular carcinoma animal model. Tumor cubes were implanted into the liver of 30 male inbred ACI rats. Groups of 10 animals were treated at 13 days (TACE or micro...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostic and interventional radiology (Ankara, Turkey) Turkey), 2017-03, Vol.23 (2), p.150-155
Main Authors: Vogl, Thomas Josef, Qian, Jun, Tran, Andreas, Oppermann, Elsie, Naguib, Nagy N, Korkusuz, Huedayi, Nour Eldin, Nour Eldin A, Bechstein, Wolf Otto
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c551t-36f7e0ca3ba5e836efcd80c00fc3a0ac6979d6460f3e78c49431d0b47f55c4463
cites
container_end_page 155
container_issue 2
container_start_page 150
container_title Diagnostic and interventional radiology (Ankara, Turkey)
container_volume 23
creator Vogl, Thomas Josef
Qian, Jun
Tran, Andreas
Oppermann, Elsie
Naguib, Nagy N
Korkusuz, Huedayi
Nour Eldin, Nour Eldin A
Bechstein, Wolf Otto
description We aimed to evaluate the combining effects of transarterial chemoembolization (TACE) and open local thermal microwave ablation in a hepatocellular carcinoma animal model. Tumor cubes were implanted into the liver of 30 male inbred ACI rats. Groups of 10 animals were treated at 13 days (TACE or microwave ablation) and 16 days (microwave ablation) postimplantation with combined therapy of TACE (0.1 mg mitomycin C; 0.1 mg iodized oil; 5.0 mg degradable starch microspheres) and microwave ablation (2450 Mhz; 45 s; 35 W) (study group A), TACE alone (control group B), or microwave ablation alone (control group C). At day 12 and day 25 tumor size was measured via magnetic resonance imaging and the relative growth ratio was calculated. Hepatic specimens were immunohistochemically examined for the expression of vascular endothelial growth factor (VEGF). Mean growth rates were 1.34±0.19 in group A, 3.19±0.13 in group B, and 4.18±0.19 in group C. Compared with control groups B and C, tumor growth rate in group A was significantly inhibited (P < 0.01). The VEGF-antibody reaction in peritumoral tissue (staining intensity at portal triad, percent antibody reaction and staining intensity at central vein) was significantly lower in group A compared with group B (P < 0.01). No significant difference between group A and group C could be observed. This investigation shows improved results of TACE followed by microwave ablation as treatment of hepatocellular carcinoma in a rat model, compared with single therapy regimen regarding the inhibition of growth rate and reduction of VEGF-level in peritumoral tissue.
doi_str_mv 10.5152/dir.2016.16617
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_2b5b8963368c4dfbb25da1d4d1c1d2f3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A508361438</galeid><doaj_id>oai_doaj_org_article_2b5b8963368c4dfbb25da1d4d1c1d2f3</doaj_id><sourcerecordid>A508361438</sourcerecordid><originalsourceid>FETCH-LOGICAL-c551t-36f7e0ca3ba5e836efcd80c00fc3a0ac6979d6460f3e78c49431d0b47f55c4463</originalsourceid><addsrcrecordid>eNptkk1v1DAQhiMEoqVw5YgsceGyix1_xLkgVRWFSpU4AGdrYo93vUrixXFalQt_vd7dtlBU-WBr5vUzmpm3qt4yupRM1h9dSMuaMrVkSrHmWXXMOJULrlj9_P6ta3lUvZqmDaVStky8rI5qzbRsW31c_fmeZ3dD4kjyGgl6jzaT6Ild4xBx6GIffkMOJW_j0IURHbkOeU2GYFO8hisk0PUHgY9pD8kJIQ847jlr3EKOFvt-7iERC8mGMQ5AwkgS5Ol19cJDP-Gbu_uk-nn--cfZ18Xlty8XZ6eXCysly6Uh3yC1wDuQqLlCb52mllJvOVCwqm1ap4SinmOjrWgFZ452ovFSWiEUP6kuDlwXYWO2KQyQbkyEYPaBmFYGUg62R1N3stOt4lwVkPNdV0sHzAnHLHO154X16cDazt2AzpZWE_SPoI8zY1ibVbwyknMtdV0AH-4AKf6accpmCNNuRjBinCfDtGqkULrd1Xr_n3QT5zSWURVVI5lQgtG_qhWUBsLoY6lrd1BzKmmZFxNcF9XyCVU5Dss644g-lPhTH8qupymhf-iRUbOznyn2Mzv7mb39yod3_07mQX7vN34LfhHXig</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1875146410</pqid></control><display><type>article</type><title>Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>Vogl, Thomas Josef ; Qian, Jun ; Tran, Andreas ; Oppermann, Elsie ; Naguib, Nagy N ; Korkusuz, Huedayi ; Nour Eldin, Nour Eldin A ; Bechstein, Wolf Otto</creator><creatorcontrib>Vogl, Thomas Josef ; Qian, Jun ; Tran, Andreas ; Oppermann, Elsie ; Naguib, Nagy N ; Korkusuz, Huedayi ; Nour Eldin, Nour Eldin A ; Bechstein, Wolf Otto</creatorcontrib><description>We aimed to evaluate the combining effects of transarterial chemoembolization (TACE) and open local thermal microwave ablation in a hepatocellular carcinoma animal model. Tumor cubes were implanted into the liver of 30 male inbred ACI rats. Groups of 10 animals were treated at 13 days (TACE or microwave ablation) and 16 days (microwave ablation) postimplantation with combined therapy of TACE (0.1 mg mitomycin C; 0.1 mg iodized oil; 5.0 mg degradable starch microspheres) and microwave ablation (2450 Mhz; 45 s; 35 W) (study group A), TACE alone (control group B), or microwave ablation alone (control group C). At day 12 and day 25 tumor size was measured via magnetic resonance imaging and the relative growth ratio was calculated. Hepatic specimens were immunohistochemically examined for the expression of vascular endothelial growth factor (VEGF). Mean growth rates were 1.34±0.19 in group A, 3.19±0.13 in group B, and 4.18±0.19 in group C. Compared with control groups B and C, tumor growth rate in group A was significantly inhibited (P &lt; 0.01). The VEGF-antibody reaction in peritumoral tissue (staining intensity at portal triad, percent antibody reaction and staining intensity at central vein) was significantly lower in group A compared with group B (P &lt; 0.01). No significant difference between group A and group C could be observed. This investigation shows improved results of TACE followed by microwave ablation as treatment of hepatocellular carcinoma in a rat model, compared with single therapy regimen regarding the inhibition of growth rate and reduction of VEGF-level in peritumoral tissue.</description><identifier>ISSN: 1305-3825</identifier><identifier>EISSN: 1305-3612</identifier><identifier>DOI: 10.5152/dir.2016.16617</identifier><identifier>PMID: 28185998</identifier><language>eng</language><publisher>Turkey: Galenos Yayinevi Tic. Ltd</publisher><subject>Ablation (Surgery) ; Animals ; Carcinoma, Hepatocellular - pathology ; Carcinoma, Hepatocellular - therapy ; Care and treatment ; Catheter Ablation - methods ; Cell Line, Tumor ; Chemoembolization, Therapeutic - methods ; Combined Modality Therapy ; Diagnosis ; Dosage and administration ; Hepatoma ; Humans ; Interventional Radiology ; Liver Neoplasms - pathology ; Liver Neoplasms - therapy ; Magnetic Resonance Imaging ; Male ; Microwaves ; Mitomycin ; Rats ; Rats, Inbred ACI ; Treatment Outcome ; Vascular endothelial growth factor ; Xenograft Model Antitumor Assays</subject><ispartof>Diagnostic and interventional radiology (Ankara, Turkey), 2017-03, Vol.23 (2), p.150-155</ispartof><rights>COPYRIGHT 2017 Galenos Yayinevi Tic. Ltd.</rights><rights>Copyright Aves Yayincilik Ltd. STI. Mar 2017</rights><rights>Copyright 2017 by the Turkish Society of Radiology 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c551t-36f7e0ca3ba5e836efcd80c00fc3a0ac6979d6460f3e78c49431d0b47f55c4463</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338582/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1875146410?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28185998$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vogl, Thomas Josef</creatorcontrib><creatorcontrib>Qian, Jun</creatorcontrib><creatorcontrib>Tran, Andreas</creatorcontrib><creatorcontrib>Oppermann, Elsie</creatorcontrib><creatorcontrib>Naguib, Nagy N</creatorcontrib><creatorcontrib>Korkusuz, Huedayi</creatorcontrib><creatorcontrib>Nour Eldin, Nour Eldin A</creatorcontrib><creatorcontrib>Bechstein, Wolf Otto</creatorcontrib><title>Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats</title><title>Diagnostic and interventional radiology (Ankara, Turkey)</title><addtitle>Diagn Interv Radiol</addtitle><description>We aimed to evaluate the combining effects of transarterial chemoembolization (TACE) and open local thermal microwave ablation in a hepatocellular carcinoma animal model. Tumor cubes were implanted into the liver of 30 male inbred ACI rats. Groups of 10 animals were treated at 13 days (TACE or microwave ablation) and 16 days (microwave ablation) postimplantation with combined therapy of TACE (0.1 mg mitomycin C; 0.1 mg iodized oil; 5.0 mg degradable starch microspheres) and microwave ablation (2450 Mhz; 45 s; 35 W) (study group A), TACE alone (control group B), or microwave ablation alone (control group C). At day 12 and day 25 tumor size was measured via magnetic resonance imaging and the relative growth ratio was calculated. Hepatic specimens were immunohistochemically examined for the expression of vascular endothelial growth factor (VEGF). Mean growth rates were 1.34±0.19 in group A, 3.19±0.13 in group B, and 4.18±0.19 in group C. Compared with control groups B and C, tumor growth rate in group A was significantly inhibited (P &lt; 0.01). The VEGF-antibody reaction in peritumoral tissue (staining intensity at portal triad, percent antibody reaction and staining intensity at central vein) was significantly lower in group A compared with group B (P &lt; 0.01). No significant difference between group A and group C could be observed. This investigation shows improved results of TACE followed by microwave ablation as treatment of hepatocellular carcinoma in a rat model, compared with single therapy regimen regarding the inhibition of growth rate and reduction of VEGF-level in peritumoral tissue.</description><subject>Ablation (Surgery)</subject><subject>Animals</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Carcinoma, Hepatocellular - therapy</subject><subject>Care and treatment</subject><subject>Catheter Ablation - methods</subject><subject>Cell Line, Tumor</subject><subject>Chemoembolization, Therapeutic - methods</subject><subject>Combined Modality Therapy</subject><subject>Diagnosis</subject><subject>Dosage and administration</subject><subject>Hepatoma</subject><subject>Humans</subject><subject>Interventional Radiology</subject><subject>Liver Neoplasms - pathology</subject><subject>Liver Neoplasms - therapy</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Microwaves</subject><subject>Mitomycin</subject><subject>Rats</subject><subject>Rats, Inbred ACI</subject><subject>Treatment Outcome</subject><subject>Vascular endothelial growth factor</subject><subject>Xenograft Model Antitumor Assays</subject><issn>1305-3825</issn><issn>1305-3612</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk1v1DAQhiMEoqVw5YgsceGyix1_xLkgVRWFSpU4AGdrYo93vUrixXFalQt_vd7dtlBU-WBr5vUzmpm3qt4yupRM1h9dSMuaMrVkSrHmWXXMOJULrlj9_P6ta3lUvZqmDaVStky8rI5qzbRsW31c_fmeZ3dD4kjyGgl6jzaT6Ild4xBx6GIffkMOJW_j0IURHbkOeU2GYFO8hisk0PUHgY9pD8kJIQ847jlr3EKOFvt-7iERC8mGMQ5AwkgS5Ol19cJDP-Gbu_uk-nn--cfZ18Xlty8XZ6eXCysly6Uh3yC1wDuQqLlCb52mllJvOVCwqm1ap4SinmOjrWgFZ452ovFSWiEUP6kuDlwXYWO2KQyQbkyEYPaBmFYGUg62R1N3stOt4lwVkPNdV0sHzAnHLHO154X16cDazt2AzpZWE_SPoI8zY1ibVbwyknMtdV0AH-4AKf6accpmCNNuRjBinCfDtGqkULrd1Xr_n3QT5zSWURVVI5lQgtG_qhWUBsLoY6lrd1BzKmmZFxNcF9XyCVU5Dss644g-lPhTH8qupymhf-iRUbOznyn2Mzv7mb39yod3_07mQX7vN34LfhHXig</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Vogl, Thomas Josef</creator><creator>Qian, Jun</creator><creator>Tran, Andreas</creator><creator>Oppermann, Elsie</creator><creator>Naguib, Nagy N</creator><creator>Korkusuz, Huedayi</creator><creator>Nour Eldin, Nour Eldin A</creator><creator>Bechstein, Wolf Otto</creator><general>Galenos Yayinevi Tic. Ltd</general><general>Aves Yayincilik Ltd. STI</general><general>Turkish Society of Radiology</general><general>Galenos Publishing House</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>EDSIH</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170301</creationdate><title>Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats</title><author>Vogl, Thomas Josef ; Qian, Jun ; Tran, Andreas ; Oppermann, Elsie ; Naguib, Nagy N ; Korkusuz, Huedayi ; Nour Eldin, Nour Eldin A ; Bechstein, Wolf Otto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c551t-36f7e0ca3ba5e836efcd80c00fc3a0ac6979d6460f3e78c49431d0b47f55c4463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Ablation (Surgery)</topic><topic>Animals</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Carcinoma, Hepatocellular - therapy</topic><topic>Care and treatment</topic><topic>Catheter Ablation - methods</topic><topic>Cell Line, Tumor</topic><topic>Chemoembolization, Therapeutic - methods</topic><topic>Combined Modality Therapy</topic><topic>Diagnosis</topic><topic>Dosage and administration</topic><topic>Hepatoma</topic><topic>Humans</topic><topic>Interventional Radiology</topic><topic>Liver Neoplasms - pathology</topic><topic>Liver Neoplasms - therapy</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Microwaves</topic><topic>Mitomycin</topic><topic>Rats</topic><topic>Rats, Inbred ACI</topic><topic>Treatment Outcome</topic><topic>Vascular endothelial growth factor</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vogl, Thomas Josef</creatorcontrib><creatorcontrib>Qian, Jun</creatorcontrib><creatorcontrib>Tran, Andreas</creatorcontrib><creatorcontrib>Oppermann, Elsie</creatorcontrib><creatorcontrib>Naguib, Nagy N</creatorcontrib><creatorcontrib>Korkusuz, Huedayi</creatorcontrib><creatorcontrib>Nour Eldin, Nour Eldin A</creatorcontrib><creatorcontrib>Bechstein, Wolf Otto</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Database‎ (1962 - current)</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Turkey Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Diagnostic and interventional radiology (Ankara, Turkey)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vogl, Thomas Josef</au><au>Qian, Jun</au><au>Tran, Andreas</au><au>Oppermann, Elsie</au><au>Naguib, Nagy N</au><au>Korkusuz, Huedayi</au><au>Nour Eldin, Nour Eldin A</au><au>Bechstein, Wolf Otto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats</atitle><jtitle>Diagnostic and interventional radiology (Ankara, Turkey)</jtitle><addtitle>Diagn Interv Radiol</addtitle><date>2017-03-01</date><risdate>2017</risdate><volume>23</volume><issue>2</issue><spage>150</spage><epage>155</epage><pages>150-155</pages><issn>1305-3825</issn><eissn>1305-3612</eissn><abstract>We aimed to evaluate the combining effects of transarterial chemoembolization (TACE) and open local thermal microwave ablation in a hepatocellular carcinoma animal model. Tumor cubes were implanted into the liver of 30 male inbred ACI rats. Groups of 10 animals were treated at 13 days (TACE or microwave ablation) and 16 days (microwave ablation) postimplantation with combined therapy of TACE (0.1 mg mitomycin C; 0.1 mg iodized oil; 5.0 mg degradable starch microspheres) and microwave ablation (2450 Mhz; 45 s; 35 W) (study group A), TACE alone (control group B), or microwave ablation alone (control group C). At day 12 and day 25 tumor size was measured via magnetic resonance imaging and the relative growth ratio was calculated. Hepatic specimens were immunohistochemically examined for the expression of vascular endothelial growth factor (VEGF). Mean growth rates were 1.34±0.19 in group A, 3.19±0.13 in group B, and 4.18±0.19 in group C. Compared with control groups B and C, tumor growth rate in group A was significantly inhibited (P &lt; 0.01). The VEGF-antibody reaction in peritumoral tissue (staining intensity at portal triad, percent antibody reaction and staining intensity at central vein) was significantly lower in group A compared with group B (P &lt; 0.01). No significant difference between group A and group C could be observed. This investigation shows improved results of TACE followed by microwave ablation as treatment of hepatocellular carcinoma in a rat model, compared with single therapy regimen regarding the inhibition of growth rate and reduction of VEGF-level in peritumoral tissue.</abstract><cop>Turkey</cop><pub>Galenos Yayinevi Tic. Ltd</pub><pmid>28185998</pmid><doi>10.5152/dir.2016.16617</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1305-3825
ispartof Diagnostic and interventional radiology (Ankara, Turkey), 2017-03, Vol.23 (2), p.150-155
issn 1305-3825
1305-3612
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_2b5b8963368c4dfbb25da1d4d1c1d2f3
source Open Access: PubMed Central; Publicly Available Content Database
subjects Ablation (Surgery)
Animals
Carcinoma, Hepatocellular - pathology
Carcinoma, Hepatocellular - therapy
Care and treatment
Catheter Ablation - methods
Cell Line, Tumor
Chemoembolization, Therapeutic - methods
Combined Modality Therapy
Diagnosis
Dosage and administration
Hepatoma
Humans
Interventional Radiology
Liver Neoplasms - pathology
Liver Neoplasms - therapy
Magnetic Resonance Imaging
Male
Microwaves
Mitomycin
Rats
Rats, Inbred ACI
Treatment Outcome
Vascular endothelial growth factor
Xenograft Model Antitumor Assays
title Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A37%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Study%20on%20the%20effect%20of%20chemoembolization%20combined%20with%20microwave%20ablation%20for%20the%20treatment%20of%20hepatocellular%20carcinoma%20in%20rats&rft.jtitle=Diagnostic%20and%20interventional%20radiology%20(Ankara,%20Turkey)&rft.au=Vogl,%20Thomas%20Josef&rft.date=2017-03-01&rft.volume=23&rft.issue=2&rft.spage=150&rft.epage=155&rft.pages=150-155&rft.issn=1305-3825&rft.eissn=1305-3612&rft_id=info:doi/10.5152/dir.2016.16617&rft_dat=%3Cgale_doaj_%3EA508361438%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c551t-36f7e0ca3ba5e836efcd80c00fc3a0ac6979d6460f3e78c49431d0b47f55c4463%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1875146410&rft_id=info:pmid/28185998&rft_galeid=A508361438&rfr_iscdi=true